Stephanie J Nahas MD, author. Dr. Nahas of Thomas Jefferson University has no relevant financial relationships to disclose.
Stephen D Silberstein MD, editor. Dr. Silberstein, Director of the Jefferson Headache Center, Thomas Jefferson University, is on the advisory panel of and receives honoraria from Allergan, MAP, Neuralieve, and NuPathe. He serves as a consultant for and receives honoraria from Amgen, Labrys Biologics, MAP, Nautilus, and Zogenix. His employer receives research support from Allergan, Amgen, Cumberland, ElectroCore, Merz, OptiNose, and Troy Healthcare.